Product Information Table
Description12.5 mg/2.5 mL (5 mg/mL) for Subcutaneous Use. Sterile, single-dose vial containing semaglutide base (non-salt form) compounded by FDA-registered 503B outsourcing facility BPI Labs (NDC: C14762). NOT FDA-APPROVED – For individualized patient use only during FDA-recognized shortages.
You've just added this product to thecart: